Trial Section
Home / Trial Section / Clinical Trial| Indication | Department | Study Title | Study Phase | Investigator | Contact Person | Status |
|---|---|---|---|---|---|---|
| 慢性腎臟病 | Cardiology | A Phase IIb, Multicentre, Randomised, Double-Blind, Dose-finding Study to Evaluate the Efficacy, Safety and Tolerability of Balcinrenone in Combination with Dapagliflozin Compared with Dapagliflozin in Patients with Chronic Kidney Disease and Albuminuria | Phase II | Tsung-Hsien Lin | 江書瑜 | On-going |
| Solid Tumor | Colorectal Surgery | A Phase 1 First-in Human, Multi-Center, Open Label Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics and RP2D of Livmoniplimab(ABBV-151) as a Single Agent and in Combination with Budigalimab(ABBV-181) in Subjects with Locally Advanced or Metastatic Solid Tumors | Phase I | WANG,JAW-YUAN | 江婕綺 | On-going |
| Myeloid Leukemia | Hematology and Oncology | A Phase 1b Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced Cancer | Phase I | Hui-Hua Hsiao | 梁素綾 | On-going |
| Plastic Surgery | A Phase 3, Multicenter, Randomized, Placebo-Controlled Study of AGN-151586 for the Treatment of Moderate to Severe Glabellar Lines | Phase III | SHU-HUNG HUANG | 鄭琪云 | On-going | |
| Infectious Diseases | A Clinical Evaluation POCKIT™ Central SARS-CoV-2 (2.0) Premix Reagent in Detect of SARS-CoV-2 | Class III | TSAI,JIH-JIN | 徐妙禎 | On-going | |
| Small Cell Lung Cance (SCLC) | Chest Medicine | A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306) | Phase III | Jen-Yu Hung | 董俞君 | On-going |
| Heart Failure | Cardiology | A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared with Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function | Phase III | Tsung-Hsien Lin | 江書瑜 | On-going |
| Hypertension | Cardiology | A Phase III, Randomised, Double -Blind, Active-controlled Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants with CKD and High Blood Pressure | Phase III | Tsung-Hsien Lin | 江書瑜 | On-going |
| Heart Failure | Cardiology | A multi-center, randomized, placebo- and active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure | Phase II | Tsung-Hsien Lin | 江書瑜 | On-going |
| 非 | Chest Medicine | A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 In Combination With Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer | Phase II | Chih-Jen Yang | 蔡詠翔 | On-going |
← Please slide to the left for more information